Significant Transactions (Summary of Asset Acquisition) (Details) |
Aug. 23, 2021
USD ($)
|
|---|---|
| Purchase price allocated | $ 7,500,000 |
| Series A-2 Preferred Stock [Member] | |
| Purchase price allocated | 1,760,000 |
| Intangible Assets [Member] | |
| Purchase price allocated | 4,300,000 |
| Prepaid Expenses [Member] | |
| Purchase price allocated | 1,440,000 |
| Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Theraputics, Inc. [Member] | |
| Purchase price allocated | $ 7,500,000 |
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|